Friday, 16 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 20, 2025

XRP’s $500M Ripple Funding at $40B Valuation: Why Price Isn’t Moving

View original at finance.yahoo.com
XRP’s $500M Ripple Funding at $40B Valuation: Why Price Isn’t Moving DUSAN ZIDAR / Shutterstock.com Quick Read Ripple (XRP) raised $500M at a $40B valuation but the token price stayed flat for six months despite institutional backing…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Ripple is expanding payment corridors and strengthening regulatory position with major institutional backing

    80% confidence
  • Enterprise adoption moves slowly and ODL corridors and RLUSD integrations don't instantly translate into higher token demand

    80% confidence
  • Base case: XRP will spend 2026 floating between $2 and $3.50, hovering around $2.50–$3 by year-end

    80% confidence
  • Bearish case: XRP could slide toward $1.50–$2 or even $1.20 if ETF flows cool, macro risks intensify, and liquidity thins

    80% confidence
  • Franklin Templeton's reputation and advisor network bring XRP into conversations it couldn't reach before, introducing slow, steady inflows from pension desks, RIAs, and conservative allocators

    80% confidence
  • If Ripple captures meaningful share of high-friction cross-border flows, XRP settlement volumes could grow several times over current levels

    80% confidence
  • Bullish case: XRP could recapture $3 zone and jump beyond $3.25 toward $5 or more by mid-2026 if institutional flows stay steady and payment rails gain traction

    80% confidence
  • Traders are focused on liquidity, whale movements, and actual settlement growth rather than big announcements

    80% confidence
  • ODL corridors help institutions move money quickly but don't require large volumes of XRP to sit on balance sheets, with token often moving only for seconds during settlement

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
XRP’s $500M Ripple Funding at $40B Valuation: Why Price Isn’t Moving — Source | Via News | ViaNews EU